$ 100 Million
Martin Shkreli Net Worth: Martin Shkreli is an Albanian American entrepreneur and hedge fund manager who has a net worth of $100 million. He is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin; and founder and former CEO of Turing Pharmaceuticals. Shkreli is also the CEO of start-up software company Gödel Systems, which he founded in August 2016. Check out the below article to know the complete information regarding Martin Shkreli Networth, His Salary, Houses, Cars, and his other Investments details. Also Check, How Much is Larry Ellison and Mark Zuckerberg Net Worth
Martin Shkreli Net Worth 2018 @ $ 100 Million
How much is Martin Shkreli Worth? (what is the net worth of Martin Shkreli)
Infamous pharmaceutical CEO Martin Shkreli has amassed a net worth of more than $100 million in just 10 years. An entrepreneur and financial executive, Shkreli co-founded the MSMB Capital Management hedge fund and became hated for hiking up the prices of lifesaving drugs when he became CEO of several pharmaceutical companies.
Shkreli was the executive chairman of Turing Pharmaceuticals and raised the price of Daraprim from $13.50 a pill to $750 after he purchased the rights to the drug from Impax Laboratories for $55 million. He is a League of Legends player and expressed interest in purchasing an esports team for $1.2 million in 2014 but was denied.
Martin Shkreli Salary and Earnings Overview
Martin Shkreli Net Worth and Earnings By Year:
|Estimated Earnings||Estimated Net Worth|
|2012 (Retrophin Pharma)||$6,359,300||$57,142,857|
|2013 (Turing Pharma)||$7,843,137||$80,000,000|
|2014 (Turing Pharma)||$10,230,179||$86,956,522|
|2015 (KaloBio Pharma)||$11,764,706||$100,000,000|
After the short intro of the ‘Pharma Bro,’ here is the brief summary of his overall earnings from his major ventures. Martin’s net worth began to maintain steep upward trajectory starting from the year 2012 after his venture, Retrophin Pharma, collected $57,142,857.
Martin got inducted in the list of ‘Forbes 30 on 30 in Finance’ in 2012. Martin improved his net worth to $80,000,000 in 2013, and $86,956,522 in 2014, thanks to Turing Pharma.
The most hated man reached up to $100,000,000 in net worth in 2015, thanks to KaloBio Pharma. Besides his successful ventures, he likes to play the game, League of Legends.’ Likewise, he purchased eSports team “Odyssey eSports in 2015. He had aimed to qualify for 2015 North American League of Legends Challenger Series.
Martin Shkreli House and Cars
There is no information regarding the House and car collection of Pharma Bro Martin Shkreli. We will update the details in this space… So, stay tuned to this page….
Drug Price-Hike Controversy:
In 2015, Shkreli started Turing Pharmaceuticals, which obtained licenses and FDA approvals for major expensive drugs within months. In September of the same year, Shkreli entered the watch of all pharmaceutical giants when he hiked the price of HIV drug Daraprim from $13.50 to a whopping $750 per tablet. This price rise resulted in the halt of many HIV treatments across the country and caused irreparable harm to thousands of patients.
|What is the Net Worth of Jeff Bezos?|
Martin Shkreli Biography | Wiki | Quick Facts
Quick Facts about Martin Shkreli:
|Full Name||Martin Shkreli|
|Net Worth||$100 Million|
|Date Of Birth||April 1, 1983|
|Place Of Birth||Brooklyn, New York, United States|
|Profession||Entrepreneur, pharmaceutical executive, CEO of “Retrophin”, “Turing Pharmaceuticals”, co-partner of KaloBios|
|Education||Hunter College High School, City-As-School High School, Baruch College|
|Nominations||NME Award for Villain of the Year|
|TV Shows||Pardon My Take Podcast (Barstool Sports, 2016)|
Martin Shkreli Instagram | Facebook | Twitter:
Hope you like this Martin Shkreli Networth article. If you like this, then please share it with your friends… This above post is all about the estimated earnings of Martin Shkreli. Do you have any queries, then feel free to ask via comment section.